Stopping the cycle of C. diff

Microbiota therapies offer exciting potential to reduce the burden of recurrent Clostridioides difficile infection, experts say.

A feature article in the Feb. 8 ACP Hospitalist focused on emerging therapies to treat patients with recurrent Clostridioides difficile infection. Experts explained how these developments could affect C. difficile care and offered tips for hospitalists.